Clinical Trial Update: Evaluation of Cilostazol in Combination With L-Carnitine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating cilostazol in combination with L-carnitine for intermittent claudication due to peripheral vascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease
• Peripheral Vascular Disease

Drugs mentioned

• Cilostazol (Cilostazol)
• L-carnitine (L-carnitine)

Snippet

Sponsor: Colorado Prevention Center | Conditions: Peripheral Vascular Disease, Intermittent Claudication | Phase 4 | Status: COMPLETED | Results posted: 2013-05-22